A Highly‐Efficient Type I Photosensitizer with Robust Vascular‐Disruption Activity for Hypoxic‐and‐Metastatic Tumor Specific Photodynamic Therapy
Source abstract
Abstract
Small 2020, 16, 2001059 https://doi.org/10.1002/smll.202001059 Some errors have been found in Figure 3e, Figure S9 and S13 in the original article. For PBV NPs and PB NPs in Figure 3e, the microscopy images demonstrating vasculature disruption at 12 h were inadvertently misused during figure compilation. In Figure S9, the images showing migration of tumor cells treated with 1.95 µg/mL PBV NPs at 0 h (row 1, column 2) and 12 h (row 2, column 2) were carelessly misused. In Figure S13, the H&E image of heart in group iv (row 1, column 4) was misused when compiling the figure. The corrected figures are shown below. These changes do not alter the conclusions of the article. And the authors apologize for any confusion.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Cancer, Hypoxia, and Metabolism
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References
Reference metadata was not supplied for this record.